Publication Details - Table of Contents

1. OVERVIEW
2. TABLE OF CONTENTS
3. CONTACT INFO
4. TECHNICAL HELP

Disclosure Policy
It is the policy of Physicians’ Education Resource to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Physicians’ Education Resource requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Physicians’ Education Resource has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity.

Caron A. Jacobson, MD
No relevant relationships to disclose

Jennifer R. Brown, MD, PhD
Research Funding – Celgene Corporation, Genzyme Corporation; Paid Consultant – Calistoga Pharmaceuticals, Inc., Genentech, Inc.

Thorsten Zenz, MD
Research Funding – Boehringer Ingelheim GmbH, GlaxoSmithKline, Roche Pharmaceuticals; Paid Consultant – Celgene Corporation, GlaxoSmithKline; Other Remuneration – Celgene Corporation, Roche Pharmaceuticals

Stephan Stilgenbauer, MD
Research Funding – Amgen, Bayer HealthCare AG, Celgene Corporation, GlaxoSmithKline, Mundipharma International Limited, Roche Pharmaceuticals; Paid Consultant – Amgen, Bayer HealthCare AG, Celgene Corporation, GlaxoSmithKline, Mundipharma International Limited, Roche Pharmaceuticals

Tadeusz Robak, MD
Research Funding – F. Hoffmann-La Roche Ltd, GlaxoSmithKline; Paid Consultant – F. Hoffmann-La Roche Ltd, GlaxoSmithKline; Speaker’s Bureau – F. Hoffmann-La Roche Ltd

PER Editorial Staff
No relevant relationships to disclose

This CME activity might include discussion of investigational and/or unlabeled uses of drugs. If the activity includes discussion of investigational and/or unlabeled uses of a drug, specific information is located on the title page. Please refer to the full prescribing information for each drug discussed in this activity for FDA-approved dosing, indications, and warnings.

Commercial Support
An educational grant for this activity was provided by GlaxoSmithKline.

Software Requirements
The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.

If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.

PC Users
If you need to upgrade your Web browser, follow one of the links listed below:

• Microsoft Internet Explorer (Outside Source)
• Mozilla Firefox (Outside Source)

Additional software requirements include:

• Adobe Flash Player (Outside Source)
• Apple iTunes for Podcast (Outside Source)
• Adobe Acrobat Reader (Outside Source)

Macintosh Users
Compatible Web browsers include:

• Mozilla Firefox (Outside Source)
• Apple Safari (Outside Source)

Additional software requirements include:

• Adobe Flash Player (Outside Source)
• Apple iTunes for Podcast (Outside Source)
• Adobe Acrobat Reader (Outside Source)

Banner Illustration
Illustrator: Erin Moore

Disclaimer
The views and opinions expressed in this activity are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this activity to ensure accuracy, the authors and Physicians’ Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this activity, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.

Please consult full prescribing information for any drugs or procedures discussed within.

Privacy Policy
Physicians’ Education Resource (PER) makes reasonable efforts to ensure that privacy issues are handled responsibly. PER does not sell or share your information with other organizations that are not directly involved in this process. If you have further concerns, you may contact us at (888) 949-0045.

All rights reserved. No part of this activity may be translated, reproduced, stored, or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.

©Copyright 2009 by Physicians’ Education Resource. No material may be reproduced in whole or in part, in any form, without written permission from the publisher.

All correspondence should be directed to:
Editor, Chronic Lymphocytic Leukemia: The Cutting Edge
Physicians’ Education Resource
3500 Maple Ave.
Suite 700
Dallas, TX 75219
Phone: (214) 367-3400
Fax: (214) 367-3304
E-mail: editor@cancerlearning.com

8633